668970-85-2 Usage
Uses
Used in Pharmaceutical Industry:
5-(4-(trifluoromethyl)phenyl)isoxazole-3-carboxylic acid is used as a building block in the synthesis of various pharmaceutical products. Its unique chemical and biological properties make it valuable for the development of new chemical entities with potential therapeutic activities.
Used in Agrochemical Industry:
5-(4-(trifluoromethyl)phenyl)isoxazole-3-carboxylic acid is also used as a building block in the synthesis of various agrochemical products. Its unique chemical and biological properties make it valuable for the development of new chemical entities with potential pesticidal activities.
Used as a Chemical Intermediate:
5-(4-(trifluoromethyl)phenyl)isoxazole-3-carboxylic acid may serve as a useful intermediate in the development of new chemical entities with potential therapeutic and pesticidal activities. Its unique structure and properties make it a promising candidate for further research and development in both medicinal and agricultural fields.
Check Digit Verification of cas no
The CAS Registry Mumber 668970-85-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,8,9,7 and 0 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 668970-85:
(8*6)+(7*6)+(6*8)+(5*9)+(4*7)+(3*0)+(2*8)+(1*5)=232
232 % 10 = 2
So 668970-85-2 is a valid CAS Registry Number.
668970-85-2Relevant academic research and scientific papers
PIPERIDINE CXCR7 RECEPTOR MODULATORS
-
Page/Page column 131; 133, (2018/02/28)
The present invention relates to piperidine derivatives of formula (I) wherein Ar1, Ar2, RAr1, R1, R2, and R3 are as described in the description, their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as CXCR7 receptor modulators.
New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis
Andrzejak, Virginie,Muccioli, Giulio G.,Body-Malapel, Mathilde,El Bakali, Jamal,Djouina, Madjid,Renault, Nicolas,Chavatte, Philippe,Desreumaux, Pierre,Lambert, Didier M.,Millet, Regis
, p. 3777 - 3786 (2011/08/03)
Growing evidence suggests a role for the endocannabinoid (EC) system, in intestinal inflammation and compounds inhibiting anandamide degradation offer a promising therapeutic option for the treatment of inflammatory bowel diseases. In this paper, we repor
ANTIBACTERIAL BENZOIC ACID DERIVATIVES
-
Page 285, (2010/02/06)
The invention provides antimicrobial agents and methods of using the agents for sterilization, sanitation, antisepsis, disinfection, and treatment of infections in mammals.
